Antigen combination | Resubstitution Classification Matrix | Leave-one-out Cross validation | Wilks lambda | f | P-value | |||
---|---|---|---|---|---|---|---|---|
 | % TB cases | % HHCs | Total % | % TB cases | % HHCs |  |  |  |
ESAT-6/CFP-10 Rv2624c Rv2389c | 86.7 (13/15) | 73.3 (11/15) | 80.0 | 73.3 (11/15) | 73.3 (11/15) | 0.59 | 18.3 | 0.0002 |
ESAT-6/CFP-10 Rv2624c Rv0867c | 86.7 (13/15) | 80.0 (12/15) | 83.3 | 73.3 (11/15) | 80.0 (12/15) | 0.60 | 17.5 | 0.0002 |
ESAT-6/CFP-10 Rv2624c Rv1009 | 73.3 (11/15) | 73.3 (11/15) | 73.3 | 66.7 (10/15) | 66.7 (10/15) | 0.62 | 16.3 | 0.0004 |
Rv2032 Rv2624c Rv0867c | 80.0 (12/15) | 78.6 (11/14) | 79.3 | 80.0 (12/15) | 71.4 (10/14) | 0.39 | 38.7 | < 0.0001 |
Rv2032 Rv2624c Rv2389c | 86.7 (13/15) | 78.6 (11/15) | 82.7 | 86.7 (13/15) | 64.3 (9/14) | 0.39 | 39.3 | < 0.0001 |
Rv2032 Rv2624c Rv1009 | 86.7 (13/15) | 71.4 (10/14) | 79.3 | 86.7 (13/15) | 64.3 (9/14) | 0.41 | 36.1 | < 0.0001 |
ESAT-6/CFP-10 Rv2032 Rv2389c | 80.0 (12/15) | 71.4 (10/14) | 75.9 | 80.0 (12/15) | 64.3 (9/14) | 0.61 | 15.9 | 0.0005 |
ESAT-6/CFP-10 Rv2032 Rv0867c | 80.0 (12/15) | 78.6 (11/14) | 79.3 | 73.3 (11/15) | 71.4 (10/14) | 0.62 | 15.6 | 0.0005 |
ESAT-6/CFP-10 Rv2032 Rv1009 | 73.3 (11/15) | 71.4 (10/14) | 72.4 | 73.3 (11/15) | 64.3 (9/14) | 0.63 | 14.5 | 0.0008 |
ESAT-6/CFP-10 Rv2032 Rv2624c | 60.0 (9/15) | 64.3 (9/14) | 62.1 | 53.3 (8/15) | 64.3 (9/14) | 0.67 | 12.5 | 0.0015 |